On April 20, 2015, the FTC announced its $26.8 million settlement with Cardinal Health, Inc. The FTC charged Cardinal Health with illegally monopolizing 25 local markets for the sale and distribution of low-energy radiopharmaceuticals, which resulted in hospitals and clinics being forced to pay inflated prices for the drugs. The $26.8 million disgorgement, the second-largest disgorgement in FTC history, will be distributed to injured customers. The Final Order and Stipulated Permanent Injunction includes an injunction and limitations regarding the purchase, sale and distribution of radiopharmaceuticals, and also requires Cardinal Health to institute an antitrust compliance program for its Nuclear Pharmacy Services business.